Group 1 - The mechanical industry showed a strong performance in 2025, with a cumulative increase of 35.07%, outperforming the Shanghai and Shenzhen 300 index (17.94%) and the Shanghai Composite Index (17.99%) [1][17][21] - Emerging sectors such as AI equipment (140%), lithium battery equipment (96%), humanoid robots (67%), and engineering machinery (55%) led the gains in the mechanical industry, indicating significant investment opportunities [1][27][25] - The outlook for 2026 suggests continued growth in AI and technology sectors, with engineering machinery expected to maintain an upward trend and domestic demand gradually recovering from the bottom [1][30][39] Group 2 - Domestic economic conditions are currently experiencing a "weak recovery" phase, with fixed asset investment showing a differentiated pattern: manufacturing > infrastructure > real estate [2][30] - The general manufacturing sector is expected to enter a new investment cycle, driven by improved PPI and inventory levels, with a focus on high-end upgrades and stock replacement [39][46] - The export sector is benefiting from the competitive strength of leading Chinese companies, with a notable increase in orders for high-end machinery from Japan, reflecting the active investment in domestic high-end manufacturing [55][56] Group 3 - The AI-driven technology sector is expected to continue its upward trend, with hardware demand and new process iterations accelerating, particularly in AI PCB technology and humanoid robots [3][30][61] - Solid-state battery technology is at a critical juncture, with leading battery companies expanding production capacity, indicating a significant opportunity for battery equipment manufacturers [3][30][61] - Investment recommendations include focusing on technology growth assets such as AI PCB equipment, humanoid robots, and solid-state battery equipment, as well as engineering machinery and general automation sectors [4][61]

Investment Rating - The industry investment rating is "Leading the Market - A" and the rating is maintained [6]. Core Viewpoints - The defense and military industry indices have declined, indicating a market correction. The China Securities Military Industry Index fell by 2.02%, the China Defense Index by 1.86%, and the Shenwan Defense and Military Industry Index by 2.15% during the week from November 7 to November 14, 2025. In comparison, the Shanghai Composite Index decreased by 0.18%, the CSI 300 Index by 1.08%, and the ChiNext Index by 3.01% [1][15]. - The Shenwan Defense and Military Industry Index ranked 27th out of 31 in terms of performance among primary industries during the same period [1][18]. Summary by Sections 1. Defense and Military Market Review - The China Securities Military Industry Index closed at 11,962.63 points, down 2.02% [1][15]. - The Shenwan Defense and Military Industry Index closed at 1,671.60 points, down 2.15% [1][15]. - The index underperformed compared to the Shanghai Composite Index and the CSI 300 Index but outperformed the ChiNext Index [1][15]. 2. Individual Stock Performance - Top performing stocks included Tian'ao Electronics (+12.63%), Shanghai Huguang (+12.35%), and Aerospace Development (+8.54%) [2][19]. - The worst performing stocks included *ST Wanfang (-19.65%), Triangle Defense (-12.22%), and Aerospace Technology (-11.83%) [2][19]. 3. Key Company Announcements - Newray Energy announced a plan to reduce its shareholding by up to 3,500,000 shares [3][21]. - Aerospace and Aerospace will hold a quarterly performance briefing on November 18, 2025 [3][21]. - China Shipbuilding announced a quarterly performance briefing scheduled for November 17, 2025 [3][21]. 4. Industry News - The U.S. Department of Defense announced plans to simplify the weapon procurement process to address global threats [11][23]. - Saab and Embraer completed aerial refueling certification flights for the Gripen E fighter and KC-390 tanker in Brazil [11][23]. - The Ministry of Industry and Information Technology released a draft for the "Medium and Long-term Technology Development Plan for the Defense Industry (2026-2035)" [11][23]. 5. Investment Recommendations - Focus on the upcoming markets for gas turbines and international subcontracting businesses, highlighting companies like Triangle Defense and Wanze Shares [11][23]. - Emphasize new-generation high-end equipment sectors, including companies like AVIC Shenyang Aircraft and AVIC Chengdu Aircraft [11][23]. - Highlight opportunities in ammunition and unmanned equipment sectors [11][23].

Industry Overview - The report rates the industry as "Leading the Market - A" indicating a positive outlook for investment opportunities in the sector [1]. Key Investment Themes - The report emphasizes the ongoing global competition in technology, particularly in the computer industry, with a focus on AI and robotics as key growth areas [2][3]. - The domestic production process in critical areas such as chips, operating systems, and databases is expected to accelerate, creating opportunities for companies with lower levels of localization [3]. AI and Robotics - The AI and robotics sectors are highlighted as having vast development potential, with rapid iterations of various models and applications in both China and the US [3]. - The report identifies the need for standard upgrades in the robotics industry, presenting both challenges and investment opportunities [3]. Quantum Technology - Quantum computing is anticipated to bring disruptive innovations in computing power, with applications in quantum secure communication and anti-quantum encryption gaining traction [3][58]. - The report outlines the potential of quantum technology across four main areas: computing, communication, measurement, and anti-quantum encryption, each showing significant growth prospects [58][59]. Database Market - The database market is projected to grow significantly, with the global market size expected to exceed $100 billion in 2023, and China's market reaching approximately 74.1 billion yuan [11]. - The report forecasts a compound annual growth rate (CAGR) of 12.23% for China's database market, reaching 93.03 billion yuan by 2028 [11]. R&D Software and Measurement Instruments - The R&D design software and electronic measurement instruments sectors are characterized by high barriers to entry, strong business models, and low localization rates, indicating a favorable environment for domestic manufacturers [5]. - The report suggests that the push for technological self-sufficiency will lead to sustained growth in these sectors [5]. Cybersecurity and Encryption - The introduction of new regulations in cybersecurity is expected to drive the growth of the encryption industry, with specific guidelines enhancing the demand for secure communication solutions [21][23]. - The report highlights the importance of establishing a robust regulatory framework to support the development of the cybersecurity sector [21]. AI Glasses and Edge AI - AI glasses are identified as a promising entry point for edge AI applications, with global sales expected to reach 90 million units by 2030, reflecting a CAGR of approximately 97.42% from 2024 to 2030 [36]. - The report notes the increasing integration of AI capabilities into consumer products, enhancing user interaction and experience [36]. Recommended Companies - The report lists several companies to watch in various sectors, including R&D software (e.g., Huada Jiutian, Gacron Electronics), cybersecurity (e.g., Sanwei Xinan, Xinan Century), and quantum technology (e.g., IonQ, Rigetti) [78][80].

Investment Rating - The report maintains an investment rating of "Outperform the Market" for the computer industry, indicating an expected return that exceeds the CSI 300 Index by 10% or more over the next six months [8]. Core Insights - The launch of the first commercial world model product, Marble, by World Labs, allows users to create editable and downloadable 3D virtual scenes from various inputs, significantly reducing scene distortion and inconsistency [1][12]. - The concept of a "world model" is introduced as a new AI system that enables machines to understand spatial relationships and interactions, moving beyond mere language descriptions [2][13]. - Major breakthroughs in world model technology have been achieved by global tech giants, including Tencent's mixed 3D world model and Google DeepMind's Genie 3, which enhances the generation of interactive virtual environments [3][14]. - Spatial intelligence is expected to empower creative tools in the short term and serve as a foundational capability for machines to understand and interact with the three-dimensional world in the medium term [4][15]. Summary by Sections Investment Recommendations - The domestic world model and physical AI industry chain is forming, with significant advancements such as the ReKep system developed by Li Feifei's team, which utilizes RGB-D cameras for 3D visual data support [5][16]. - Recommended stocks include: - Oboe Technology (leader in 3D visual perception) - Zhiwei Intelligent (robotic brain controller) - Suochen Technology (physical AI product developer) - Alter (investing in the robotics sector) [5][16]. Market Performance Review - The computer sector underperformed relative to the CSI 300 Index, with a decline of 3.72% this week, while the overall market indices showed mixed results [17][18]. - The computer industry index ranked 28th among 30 industry indices, indicating weaker performance compared to other sectors [20]. Industry News - The report highlights significant developments in quantum applications in Anhui province, aiming for 1,000 application scenarios by 2027, and the departure of Meta's chief AI scientist, who plans to establish a world model company [24][25].

Investment Rating - The report maintains an investment rating of "Outperform the Market - A" [4] Core Views - The report is optimistic about the continuation of the metal bull market in 2026, particularly for precious metals, industrial metals (copper, aluminum, tin), rare earths, tungsten, and uranium [1][2] - Gold is expected to rise due to increased demand for hedging against dollar credit and policy uncertainties, with a focus on the potential for new highs in gold prices [1][18] - Industrial metals like copper and aluminum are facing supply constraints, while tin demand is on the rise, indicating a favorable outlook for these metals [2][8] Summary by Sections Gold - The report highlights the strengthening of gold prices driven by concerns over U.S. dollar credit and rising geopolitical uncertainties, with gold prices reaching $3999.4 per ounce as of November 7, 2025, a 52% increase from the previous year [17][18] - The Federal Reserve's interest rate cuts are expected to further support gold prices, with a projected decline in the policy rate to 3-3.25% by the end of 2026 [21][22] - Key stocks to watch include Shandong Gold, Shandong International, and China National Gold [1] Copper - The report notes increasing supply constraints in copper mining, with production disruptions leading to a downward revision of copper output forecasts for 2025 [1][2] - Demand for copper is expected to grow significantly due to the rise of electric vehicles and investments in global power grids, with a notable increase in demand from AI data centers [1][2][18] - Key stocks to monitor include Luoyang Molybdenum, Jinchuan Group, and Jiangxi Copper [1] Aluminum - The aluminum market is characterized by tight supply and strong demand, with domestic production nearing capacity limits and a projected price increase to around 21,500 yuan per ton by 2026 [2] - The report anticipates a supply-demand gap in the aluminum market, supporting price increases [2] - Key stocks to consider include Nanshan Aluminum, China Hongqiao, and Yunnan Aluminum [2] Tin - The tin market is expected to see price increases driven by stable supply and rising demand from sectors like semiconductors and consumer electronics, with global refined tin consumption projected to grow by 3.1% in 2026 [8] - Key stocks to watch include Yunnan Tin and Hunan Tin [8] Rare Earths - The report indicates a slowdown in supply quota growth for rare earths, but strong demand from the renewable energy sector is expected to improve the supply-demand balance [8] - The global demand for neodymium-iron-boron is projected to grow significantly, with a compound annual growth rate of 8.83% from 2020 to 2028 [8] - Key stocks to monitor include China Rare Earth and Northern Rare Earth [8] Tungsten - The tungsten market is expected to remain tight, with prices likely to continue rising due to limited supply and stable demand [8] - Key stocks to consider include Xiamen Tungsten and Zhongtung High-tech [8] Cobalt - The cobalt market is facing supply constraints, with a significant drop in imports of cobalt intermediates into China, leading to a tight supply situation [10] - Demand from the electric vehicle sector is expected to support cobalt prices [10] - Key stocks to watch include Luoyang Molybdenum and Huayou Cobalt [10] Uranium - The uranium market is entering a new cycle of growth due to supply constraints and a revival in nuclear power, with a projected supply-demand gap of approximately 7,452 tons by 2030 [11] - Key stocks to monitor include China National Nuclear Corporation [11]

Investment Rating - The report maintains an investment rating of "Leading the Market-A" for the construction industry [4]. Core Viewpoints - Infrastructure investment in October showed a month-on-month decline, with a focus on the high prosperity of the western region and cleanroom sector [1][2]. - The overall fixed asset investment (excluding rural households) from January to October reached 40.89 trillion yuan, a year-on-year decrease of 1.7%, with October's investment down by 1.62% [1][16]. - The report suggests that despite the decline in investment growth rates, the construction sector is expected to benefit from policy catalysts and marginal improvements in fundamentals, particularly in Q4, which is traditionally a peak construction season [2][10]. Summary by Sections Industry Dynamics Analysis - From January to October, narrow and broad infrastructure investments recorded year-on-year changes of -0.10% and 1.51%, respectively, with a continuous month-on-month decline since April [1][16]. - In the three major infrastructure categories, investment in electricity, heat, gas, and water maintained a double-digit growth rate, increasing by 12.50% year-on-year [1][16]. Market Performance - The construction industry rose by 0.35% this week, underperforming compared to major indices like the Shenzhen Composite Index and the CSI 300 [19][20]. - The report highlights that 60.98% of companies in the construction sector recorded gains, with notable performers including Guosheng Technology and Dongyi Risheng [20][26]. Key Investment Targets - The report recommends focusing on undervalued construction enterprises, particularly state-owned enterprises in the western region and those involved in coal chemical projects [2][10]. - Specific recommendations include low-valuation central construction enterprises such as China State Construction, China Communications Construction, and China Railway Construction [10][11]. Company Announcements - Significant contract announcements include China Railway's new contracts totaling 8,450.7 billion yuan from January to October, reflecting a year-on-year decrease of 11.8% [29]. - The report also notes that several companies have secured major contracts, indicating ongoing project activity in the sector [28]. Industry News - The report discusses the government's measures to promote private investment in major engineering projects, aiming to enhance participation from private capital [30]. - It also highlights the importance of optimizing project reviews and enhancing collaboration among departments to support infrastructure development [30].

Group 1 - The core view of the report indicates that the innovative drug market is expected to drive continuous valuation recovery in the pharmaceutical sector, supported by improving fundamentals and overseas expansion catalysts [2][7][10] - The pharmaceutical sector's overall performance shows a slight revenue growth of 0.2% year-on-year in Q3 2025, while net profit attributable to the parent company decreased by 12.87% [4][3] - The report highlights that the revenue of domestic biotech innovative drug companies reached 52.13 billion yuan in H1 2025, marking a 14% year-on-year increase, indicating that commercialization is entering a rapid growth phase [21][24] Group 2 - The report notes that the total overseas licensing business development (BD) transaction amount in the innovative drug sector exceeded 100 billion USD in 2025, with expectations for continued growth in 2026 [27][30][33] - The report emphasizes that the innovative drug sector's valuation remains at a historically low level, with the median PE ratio for the pharmaceutical sector at 34.21 times, suggesting potential for further recovery [10][57] - Institutional enthusiasm for the biotech innovative drug sector is reflected in the increasing proportion of holdings, with the weight of all funds in the biotech sector rising to 2.66% in Q3 2025 [11][35][38] Group 3 - The report identifies key companies to watch, including Sanofi Biopharma, which has licensed a PD-1/VEGF dual antibody to Pfizer, indicating high certainty for future overseas sales growth [63] - The report also highlights the potential of Union Pharmaceuticals' UBT251, which has shown promising results in weight loss and is licensed to Novo Nordisk [63] - The report suggests that Kolon Biotech's TROP2 ADC, licensed to Merck, has demonstrated excellent data and is expected to have significant market potential [63]

Investment Rating - The report maintains an investment rating of "Outperform" with a target price set for the next six months [4]. Core Insights - Alibaba has launched the "Qianwen" project, aiming to compete with ChatGPT by developing a personal AI assistant app, leveraging its Qwen model, which has a pre-training data volume of 36 trillion tokens and over one trillion parameters [1]. - SanDisk has raised NAND flash memory prices by 50%, indicating a tightening storage chip market driven by strong demand from AI data centers and limited global wafer production capacity [2]. - Baidu has unveiled its AI chip roadmap, introducing the Kunlun M100 and M300 chips, with plans to release new products annually over the next five years [3]. Summary by Sections Industry News Overview - The report highlights significant developments in the semiconductor and AI sectors, including the completion of the first phase of 6G technology trials in China and advancements in silicon carbide (SiC) technology [16][17]. Market Performance Review - The electronic sector experienced a decline of 4.77% in the week of November 10-14, 2025, ranking 30 out of 31 in overall industry performance [31][33]. - The report notes that the semiconductor sub-sector has a high price-to-earnings (PE) ratio of 95.27, indicating strong market expectations [40]. Investment Recommendations - The report suggests focusing on companies in the domestic computing power sector such as Feirongda and Xingsen Technology, as well as storage industry players like Zhaoyi Innovation and Bawei Storage [10].

Investment Rating - The report maintains an investment rating of "Outperform" [4] Core Insights - The innovative drug sector is experiencing a surge in business development (BD) transactions, with expectations for multiple BD deals to emerge in Q4 2025. As of October 2025, there have been 175 overseas licensing BD transactions in the domestic innovative drug sector, with a total contract value of $104.2 billion and upfront payments reaching $8.1 billion, surpassing the total figures for the entire year of 2024 [2][17][18]. Summary by Sections Weekly New Drug Market Review - From November 10 to November 16, 2025, the top five gainers in the new drug sector were: - Gilead Sciences (+45.40%) - Lai Kai Pharmaceutical (+27.93%) - Jiahe Biopharma (+24.61%) - Zhongsheng Pharmaceutical (+24.46%) - Kaitu Pharmaceutical (+22.81%) - The top five losers were: - Yongtai Biopharma (-7.74%) - Junsheng Tai (-7.43%) - Weixin Biopharma (-1.87%) - Zai Ding Pharmaceutical (-0.93%) - Maibo Pharmaceutical (-0.00%) [1][13][15] Recommended Focus Stocks - The report suggests focusing on several stocks with potential catalysts, including: 1. Products with high overseas sales certainty certified by MNCs: - PD-1 upgraded product: Sanofi - GLP-1 asset: Lianbang Pharmaceutical - ADC asset: Kelun-Botai 2. Potential heavyweights for overseas licensing from MNCs: - PD-1 upgraded product: Kangfang Biopharma - Breakthroughs in autoimmune fields: Yifang Biopharma, China Antibody - Innovative target ADC: Fuhong Hanlin, Shiyao Group 3. Stocks likely to benefit from medical insurance negotiations and commercial insurance innovative drug directories: - Expected beneficiaries from medical insurance directory: Hengrui Medicine, Kangnuo Pharmaceutical, Maiwei Biopharma, Zhixiang Jintai, Haichuang Pharmaceutical - Expected beneficiaries from commercial insurance innovative drug directory: WuXi AppTec, Kexin Pharmaceutical [2][17] New Drug Approval and Acceptance - This week, four new drugs or new indications received approval, and six new drugs or new indications were accepted for review [3][24]. Clinical Application Approval and Acceptance - This week, 43 new drug clinical applications were approved, and 43 new drug clinical applications were accepted [7][27].

Group 1 - The report highlights a divergence between the stock market and the macroeconomic fundamentals, with the Shanghai Composite Index rising approximately 15% in the second half of the year despite weak economic data, such as a 2.9% year-on-year growth in retail sales in October, which is at a yearly low [1][2][3] - The report suggests that the transition from a "liquidity bull" market to a "fundamental bull" market is necessary for the Shanghai Composite Index to maintain its position above 4000 points, emphasizing the importance of monitoring the easing of political cycles and economic recovery [2][3] - The report indicates that the A-share market is experiencing a significant style rotation, with a notable shift from high-growth sectors to value sectors, particularly in the context of the "high cut low" market behavior observed since early September [3][31][38] Group 2 - The report notes that the technology sector has shown significant internal differentiation, with strong performance in sectors supported by fundamentals, such as AI hardware, while software applications and weaker performance sectors have lagged [3][43][49] - The report emphasizes the importance of upcoming earnings reports from major tech companies, such as Nvidia and Alibaba, as they will provide critical signals regarding the sustainability of the tech sector's performance and its impact on global risk assets [52][59] - The report predicts that the technology sector may underperform in the fourth quarter but could rebound in the early part of the next year, based on historical trends and the current dependence on global AI industry trends [53][56][62] Group 3 - The report highlights that the Hong Kong stock market has seen a structural divergence, with high dividend yield stocks outperforming the Hang Seng Index and Hang Seng Tech Index, driven by significant inflows from southbound capital [4][26][27] - The report indicates that the energy and financial sectors have shown strong performance compared to information technology and consumer discretionary sectors, reflecting a shift in investor preference towards value stocks [4][26][27] - The report suggests that the performance of the Hong Kong tech sector is constrained by the strengthening of the US dollar and the recent hawkish signals from the Federal Reserve, which have dampened market liquidity expectations [4][26][27]